Curemeta LLC to Present at IBC Life Science 2015
Curemeta LLC, a Boston-based oncology biotech, will be at the IBC Life Science Conference in San Francisco. They will be presenting data on their ADCs which target pluripotent cancer stem cells. - May 16, 2015
Curemeta LLC to Present at PEGS Boston
Curemeta LLC, a Boston-based biotech focused on developing antibody drug conjugate therapies for metastatic cancers, announced that they will be presenting their data on novel ADC therapies at the essential Protein Engineering Summit (PEGS) taking place at the Seaport World Trade Center in Boston... - May 03, 2015
Press Releases 1 - 2 of 2